Study of the effect of Riluzole on tinnitus treatment

Phase 3

Recruiting

• Conditions: Tinnitus.; Tinnitus

• Registration Number: IRCT20100126003181N2
• Lead Sponsor: Vice-chancellor for research,Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Having a chief complaint of tinnitus
Aged between 18-70
Tinnitus More than 3 months

Exclusion Criteria

Middle and external ear disease
Patients with conductive and mixed hearing loss
The presence of the Pulsatile tinnitus type
The presence of temporomandibular joint disorders
Receiving medications with Systemic effects (in relation to tinnitus) over the past 6 months
The presence of tinnitus with a period Less than three months
Mild tinnitus (about THI <36)
Patients with liver and renal failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pure tone audiometry. Timepoint: The first day and the 90th day of study. Method of measurement: PTA test.;Tinnitus severity. Timepoint: The first day and the 90th day of study. Method of measurement: THI ( tinnitus handicap inventory) questionnaire.

Secondary Outcome Measures

Name	Time	Method
Tinnitus pitch match. Timepoint: The first day and the 90th day of study. Method of measurement: An assessment by an audiologist.;Drug side effect. Timepoint: fourth week. Method of measurement: ask from patient.;Maskability. Timepoint: The first day and the 90th day of study. Method of measurement: An assessment by an audiologist.;Tinnitus loudness match. Timepoint: The first day and the 90th day of study. Method of measurement: An assessment by an audiologist.